Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Form 8 (OPD)

21 May 2025 11:10

RNS Number : 6116J
TA Associates Management, L.P
21 May 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Kairos Bidco Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FD Technologies plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

21 May 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of £0.005 each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

A portfolio company of certain funds managed by TA Associates holds the following interest in ordinary shares of £0.005 each in FD Technologies plc through certain funds managed by the portfolio company. Under the Code, such portfolio company is deemed to be a person acting in concert with the offeror. However, TA Associates does not have any involvement in such portfolio company's asset management activities.

 

Name

Number of ordinary shares

Percentage of issued share capital (per cent.)

Russell Investments

108,118

0.48%

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

21 May 2025

Contact name:

Arthur Price

Telephone number:

+1 617 574 6700

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEABMMTMTMTBAA
Date   Source Headline
17th Aug 20074:59 pmRNSDisclosure of Information
3rd Aug 200712:01 pmRNSExercise of options
27th Jul 20073:11 pmRNSTotal Voting Rights
6th Jul 200712:41 pmRNSExercise of Options
8th Jun 20077:00 amRNSIEX Notice
7th Jun 20072:08 pmRNSResult of AGM
6th Jun 20075:27 pmRNSIEX Schedule One Update
21st May 200710:32 amRNSDirector/PDMR Shareholding
18th May 200710:21 amRNSFinal Results - REPLACEMENT
10th May 200710:48 amRNSIEX Schedule One
10th May 20077:01 amRNSFinal Results
3rd Apr 20079:29 amRNSTotal Voting Rights
6th Mar 20071:25 pmRNSExercise of Options
28th Feb 20073:14 pmRNSTotal Voting Rights
27th Feb 20072:07 pmRNSIssue of Equity
8th Feb 20077:00 amRNSTrading Statement
31st Jan 20071:55 pmRNSTotal Voting Rights
30th Jan 20077:01 amRNSExercise of Options
12th Jan 20075:24 pmRNSDirector/PDMR Shareholding
11th Jan 20074:59 pmRNSDirector/PDMR Shareholding
20th Dec 20064:29 pmRNSTotal Voting Rights
20th Dec 20064:20 pmRNSIssue of Equity
19th Oct 20063:41 pmRNSDirector/PDMR Shareholding
5th Oct 20068:52 amRNSExercise of Options
26th Sep 20067:01 amRNSInterim Results
1st Jun 200612:05 pmRNSResult of AGM
22nd May 20063:09 pmRNSDirector/PDMR Shareholding
9th May 20065:53 pmRNSDividend Update Statement
9th May 20067:01 amRNSFinal Results
24th Apr 20062:50 pmRNSNotice of Results
17th Mar 20067:02 amRNSTrading Statement
10th Mar 20062:49 pmRNSExercise of Options
10th Mar 20062:38 pmRNSDirector/PDMR Shareholding
24th Nov 20057:01 amRNSDirectorate Change
7th Oct 20053:24 pmRNSDirector/PDMR Shareholding
22nd Sep 20057:00 amRNSInterim Results
28th Jun 20055:26 pmRNSResult of AGM
27th May 20052:37 pmRNSDividend Declaration
25th May 20057:01 amRNSFinal Results
3rd May 20057:00 amRNSTrading update
9th Feb 20052:32 pmRNSNew Contract Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.